UK industry body finds AstraZeneca in breach of code over Symbicort marketing

AstraZeneca breached the UK pharmaceutical industry's code of practice after a website claim incorrectly stated that all ...
Hosted on MSN

What to Know About Symbicort (Budesonide and Formoterol)

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called budesonide ...
PharmiWeb

AstraZeneca's Symbicort gives asthma patients the power to get SMART

The SMART (Symbicort Maintenance and Reliever Therapy) approach allows patients to increase the dose of Symbicort (a combination of an inhaled corticosteroid and long-acting bronchodilator) during ...
pharmaphorum

AZ, Organon fall foul of UK's code on pharma promotion

AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...
Fierce Healthcare

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
FiercePharma

SYMBICORT® (budesonide/formoterol fumarate dihydrate) Study in African American Patients With Asthma Shows Improved Lung Functio

(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
FierceBiotech

AstraZeneca spins up new partnership with Propeller Health to add smart features to its Symbicort inhaler

With a new clearance from the FDA, smart inhaler developer Propeller Health is bringing its connected platform to AstraZeneca’s Symbicort to help digitize the treatment of asthma and chronic ...
FierceBiotech

AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R)

Howard Hutchinson, M.D., Chief Medical Officer of AstraZeneca, said, "The safety and efficacy of SYMBICORT have been demonstrated in numerous clinical trials and from extensive post-marketing use ...
Nasdaq

FDA Approves First Generic Of Symbicort To Treat Asthma, COPD

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
Medscape

FDA Approvals: Symbicort and Synvisc-One

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
EurekAlert!

AstraZeneca submits an sNDA for Symbicort for treatment of asthma in children as young as 6

Wilmington, DE – June 4, 2008 – AstraZeneca (NYSE: AZN) today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...
FiercePharma

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

After seeing four of its patents for its Symbicort tossed aside, AstraZeneca has gained a key victory in defense of its blockbuster inhaler. A federal court in West Virginia upheld the company’s claim ...